Chemical Composition and Cytotoxic Activity of <i>Chenopodium ambrosioides</i> L. Essential Oil from Togo
Keywords:Chenopodium ambrosioides, Essential oil, Ascaridole, p-cymene, HaCaT cell line, Cytotoxicity
The leaf essential oil of Chromolaena odorata L. (Chenopodiaceae) from Togo were steam-distilled, analyzed by GC and GC-MS for chemical composition and investigated in vitro for its potential cytotoxic activity on human epidermic cell line HaCat. The chemical composition showed that the main constituents of essential oil sample were respectively ascaridole (51.12 %), p-cymene (19.88 %), neral (8.70%) and geraniol (7.55%). The in vitro cytotoxicity bioassays on human cell line HaCaT revealed moderate toxicity level of C. ambrosioides essential oil IC50 with 700 μL.mL-1. Pure commercial neral standard showed high toxicity with IC50 value of 100 μL.mL-1). Conversely, pure ascaridole p-cymene and geraniol standards appeared almost non-toxic (IC50 >1000 μL.mL-1), proving the major role played by neral in the overall toxicity showed by the C. ambrosiodes oil sample tested in this work.
Keywords: Chenopodium ambrosioides; Essential oil; Ascaridole; p-cymene; HaCaT cell line; Cytotoxicity.
Bangladesh J. Sci. Ind. Res. 44(4), 435-440, 2009
How to Cite
Bangladesh Council of Scientific and Industrial Research (BCSIR) holds the copyright to all contents published in Bangladesh Journal of Scientific and Industrial Research (BJSIR). A copyright transfer form should be signed by the author(s) and be returned to BJSIR.
The entire contents of the BJSIR are protected under Bangladesh Council of Scientific and Industrial Research (BCSIR) copyrights.
BJSIR is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC) Creative Commons Attribution-NonCommercial 4.0 International License which allows others remix, tweak, and build upon the articles non-commercially, and although their new works must also acknowledge and be non-commercial, they dont have to license their derivative works on the same terms.